Daily market insights on Telegram
Share Predictions

Stocks

Stock predictionsToday's rankings and AI sentiment SectorsWhere each part of the market leans Stock directoryEvery U.S. stock, A to Z AI trading portfolioA simulation of the predictions Penny stocks portfolioA simulation, for penny stocks

Options

Options chainCalls and puts for any U.S. stock Options predictionsEvery closed one, wins and losses Options directoryEvery optionable stock, A to Z Options guidesFrom Greeks to spreads, in plain words

Apps

SharePredsStocks OpPredsOptions CPredsCrypto TradeSimSimulator Average CostCalculator All apps

Tools

All trading tools Get SharePreds

Acadia Pharmaceuticals Inc. (ACAD) stock analysis and AI prediction

The company facts of Acadia Pharmaceuticals Inc., with its price and AI prediction for the next 10 market days in SharePreds.

Keep looking in SharePreds

You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.

QR code that opens SharePreds in your phone's app storeScan with your phone
See all five apps
SharePreds ranking U.S. stocks by their chance of rising over the next 10 days

About Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases. Its neurological disease franchise is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. FDA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Exchange
NASDAQ
Market value
$3.1 billion
Employees
798
Headquarters
SAN DIEGO, CA
Listed since
May 27, 2004
Website
acadia.com

ACAD questions

What is the AI prediction for ACAD stock?

Each market day our model rates Acadia Pharmaceuticals Inc. (ACAD) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.

How often is the ACAD prediction updated?

Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.

What do Bullish, Neutral and Bearish mean?

Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.

Where can I see the exact likelihood for ACAD?

In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.

Where can I see ACAD options?

The ACAD options page opens its calls and puts, with price, volume, implied volatility and the Greeks.